TSH Biopharm Corporation Limited - 8432.TWO - Fundamentals

Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.

Insider Tracker is here!

Try it now Watch the presentation

‌
‌

‌

Let's get started...

‌

Breakdown	2019 12/31	2020 12/31	2021 12/31	2022 12/31	2023 12/31	2024 12/31	2025 12/31	TTM
REVENUE	508	448	413	741	811	1,116	1,337	1,397	📊
Revenue Growth (1Y)	--	-11.78%	-7.68%	+79.23%	+9.43%	+37.59%	+19.79%	+4.50%	📊
Revenue Growth (5Y)	--	--	--	--	+59.73%	+149.12%	+223.24%	+237.77%	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	--	📊
Cost of Revenue	203	163	166	351	411	533	656	693	📊
Cost of Revenue Growth (1Y)	--	-19.69%	+2.12%	+111.40%	+17.03%	+29.67%	+23.05%	+5.74%	📊
Cost of Revenue Growth (5Y)	--	--	--	--	+102.92%	+227.63%	+294.75%	+317.42%	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	--	📊
Gross Profit	305	285	247	390	400	583	681	703	📊
Gross Profit Growth (1Y)	--	-6.53%	-13.27%	+57.61%	+2.57%	+45.73%	+16.81%	+3.30%	📊
Gross Profit Growth (5Y)	--	--	--	--	+31.06%	+104.34%	+175.20%	+184.28%	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	--	📊
Operating Expenses	249	211	192	321	336	412	462	450	📊
Operating Expenses Growth (1Y)	--	-15.24%	-9.08%	+67.22%	+4.82%	+22.56%	+12.19%	-2.66%	📊
Operating Expenses Growth (5Y)	--	--	--	--	+35.09%	+95.34%	+141.01%	+134.61%	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	--	📊
Sell General Administrative	197	182	168	290	313	384	0	294	📊
Research and Development	52	29	24	31	25	28	0	19	📊
Other Income Expenses	0	1	4	13	0	0	462	137	📊
EBITDA	113	87	71	107	99	203	218	282	📊
EBITDA Growth (1Y)	--	-23.21%	-17.85%	+49.35%	-6.72%	+104.17%	+7.66%	+29.01%	📊
EBITDA Growth (5Y)	--	--	--	--	-12.12%	+133.68%	+206.21%	+295.04%	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	--	📊
Depreciation and Amortization	10	10	10	22	23	29	0	21	📊
Operating Income	56	77	62	85	64	171	218	253	📊
Operating Income Growth (1Y)	--	+37.29%	-20.25%	+38.11%	-25.12%	+168.14%	+27.99%	+15.90%	📊
Operating Income Growth (5Y)	--	--	--	--	+13.22%	+121.14%	+254.91%	+311.34%	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	--	📊
Interest Expense	0	0	0	1	1	0	0	1	📊
Pre Tax Income	103	77	62	81	76	173	235	270	📊
Tax Provision	18	16	14	15	11	39	47	52	📊
NET INCOME	85	62	47	62	62	113	188	183	📊
Net Income Growth (1Y)	--	-27.84%	-23.49%	+31.38%	+0.16%	+82.44%	+66.07%	-2.62%	📊
Net Income Growth (5Y)	--	--	--	--	-27.35%	+83.68%	+298.70%	+288.26%	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	--	📊
Basic EPS	2.22	1.6	1.23	1.61	1.61	2.94	3.63	4.35	📊
Diluted EPS	2.22	1.6	1.23	1.61	1.61	2.94	3.63	4.35	📊
Basic Average Shares	38	38	38	38	38	38	52	45	📊
Diluted Average Shares	38	38	38	38	38	39	52	45	📊

Breakdown

2019

12/31

2020

12/31

2021

12/31

2022

12/31

2023

12/31

2024

12/31

2025

12/31

TTM

REVENUE

508

448

413

741

811

1,116

1,337

1,397

📊

Revenue Growth (1Y)

-11.78%

-7.68%

+79.23%

+9.43%

+37.59%

+19.79%

+4.50%

📊

Revenue Growth (5Y)

+59.73%

+149.12%

+223.24%

+237.77%

📊

Revenue Growth (10Y)

📊

Cost of Revenue

203

163

166

351

411

533

656

693

📊

Cost of Revenue Growth (1Y)

-19.69%

+2.12%

+111.40%

+17.03%

+29.67%

+23.05%

+5.74%

📊

Cost of Revenue Growth (5Y)

+102.92%

+227.63%

+294.75%

+317.42%

📊

Cost of Revenue Growth (10Y)

📊

Gross Profit

305

285

247

390

400

583

681

703

📊

Gross Profit Growth (1Y)

-6.53%

-13.27%

+57.61%

+2.57%

+45.73%

+16.81%

+3.30%

📊

Gross Profit Growth (5Y)

+31.06%

+104.34%

+175.20%

+184.28%

📊

Gross Profit Growth (10Y)

📊

Operating Expenses

249

211

192

321

336

412

462

450

📊

Operating Expenses Growth (1Y)

-15.24%

-9.08%

+67.22%

+4.82%

+22.56%

+12.19%

-2.66%

📊

Operating Expenses Growth (5Y)

+35.09%

+95.34%

+141.01%

+134.61%

📊

Operating Expenses Growth (10Y)

📊

Sell General Administrative

197

182

168

290

313

384

294

📊

Research and Development

📊

Other Income Expenses

462

137

📊

EBITDA

113

107

203

218

282

📊

EBITDA Growth (1Y)

-23.21%

-17.85%

+49.35%

-6.72%

+104.17%

+7.66%

+29.01%

📊

EBITDA Growth (5Y)

-12.12%

+133.68%

+206.21%

+295.04%

📊

EBITDA Growth (10Y)

📊

Depreciation and Amortization

📊

Operating Income

171

218

253

📊

Operating Income Growth (1Y)

+37.29%

-20.25%

+38.11%

-25.12%

+168.14%

+27.99%

+15.90%

📊

Operating Income Growth (5Y)

+13.22%

+121.14%

+254.91%

+311.34%

📊

Operating Income Growth (10Y)

📊

Interest Expense

📊

Pre Tax Income

103

173

235

270

📊

Tax Provision

📊

NET INCOME

113

188

183

📊

Net Income Growth (1Y)

-27.84%

-23.49%

+31.38%

+0.16%

+82.44%

+66.07%

-2.62%

📊

Net Income Growth (5Y)

-27.35%

+83.68%

+298.70%

+288.26%

📊

Net Income Growth (10Y)

📊

Basic EPS

2.22

1.6

1.23

1.61

2.94

3.63

4.35

📊

Diluted EPS

2.22

1.6

1.23

1.61

2.94

3.63

4.35

📊

Basic Average Shares

📊

Diluted Average Shares

📊

Breakdown	2019 12/31	2020 12/31	2021 12/31	2022 12/31	2023 12/31	2024 12/31	2025 12/31	TTM
REVENUE	508	448	413	741	811	1,116	1,337	1,397	📊
Revenue Growth (1Y)	--	-11.78%	-7.68%	+79.23%	+9.43%	+37.59%	+19.79%	+4.50%	📊
Revenue Growth (5Y)	--	--	--	--	+59.73%	+149.12%	+223.24%	+237.77%	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	--	📊
Cost of Revenue	203	163	166	351	411	533	656	693	📊
Cost of Revenue Growth (1Y)	--	-19.69%	+2.12%	+111.40%	+17.03%	+29.67%	+23.05%	+5.74%	📊
Cost of Revenue Growth (5Y)	--	--	--	--	+102.92%	+227.63%	+294.75%	+317.42%	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	--	📊
Gross Profit	305	285	247	390	400	583	681	703	📊
Gross Profit Growth (1Y)	--	-6.53%	-13.27%	+57.61%	+2.57%	+45.73%	+16.81%	+3.30%	📊
Gross Profit Growth (5Y)	--	--	--	--	+31.06%	+104.34%	+175.20%	+184.28%	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	--	📊
Operating Expenses	249	211	192	321	336	412	462	450	📊
Operating Expenses Growth (1Y)	--	-15.24%	-9.08%	+67.22%	+4.82%	+22.56%	+12.19%	-2.66%	📊
Operating Expenses Growth (5Y)	--	--	--	--	+35.09%	+95.34%	+141.01%	+134.61%	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	--	📊
Sell General Administrative	197	182	168	290	313	384	0	294	📊
Research and Development	52	29	24	31	25	28	0	19	📊
Other Income Expenses	0	1	4	13	0	0	462	137	📊
EBITDA	113	87	71	107	99	203	218	282	📊
EBITDA Growth (1Y)	--	-23.21%	-17.85%	+49.35%	-6.72%	+104.17%	+7.66%	+29.01%	📊
EBITDA Growth (5Y)	--	--	--	--	-12.12%	+133.68%	+206.21%	+295.04%	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	--	📊
Depreciation and Amortization	10	10	10	22	23	29	0	21	📊
Operating Income	56	77	62	85	64	171	218	253	📊
Operating Income Growth (1Y)	--	+37.29%	-20.25%	+38.11%	-25.12%	+168.14%	+27.99%	+15.90%	📊
Operating Income Growth (5Y)	--	--	--	--	+13.22%	+121.14%	+254.91%	+311.34%	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	--	📊
Interest Expense	0	0	0	1	1	0	0	1	📊
Pre Tax Income	103	77	62	81	76	173	235	270	📊
Tax Provision	18	16	14	15	11	39	47	52	📊
NET INCOME	85	62	47	62	62	113	188	183	📊
Net Income Growth (1Y)	--	-27.84%	-23.49%	+31.38%	+0.16%	+82.44%	+66.07%	-2.62%	📊
Net Income Growth (5Y)	--	--	--	--	-27.35%	+83.68%	+298.70%	+288.26%	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	--	📊
Basic EPS	2.22	1.6	1.23	1.61	1.61	2.94	3.63	4.35	📊
Diluted EPS	2.22	1.6	1.23	1.61	1.61	2.94	3.63	4.35	📊
Basic Average Shares	38	38	38	38	38	38	52	45	📊
Diluted Average Shares	38	38	38	38	38	39	52	45	📊

Breakdown

2019

12/31

2020

12/31

2021

12/31

2022

12/31

2023

12/31

2024

12/31

2025

12/31

TTM

REVENUE

508

448

413

741

811

1,116

1,337

1,397

📊

Revenue Growth (1Y)

-11.78%

-7.68%

+79.23%

+9.43%

+37.59%

+19.79%

+4.50%

📊

Revenue Growth (5Y)

+59.73%

+149.12%

+223.24%

+237.77%

📊

Revenue Growth (10Y)

📊

Cost of Revenue

203

163

166

351

411

533

656

693

📊

Cost of Revenue Growth (1Y)

-19.69%

+2.12%

+111.40%

+17.03%

+29.67%

+23.05%

+5.74%

📊

Cost of Revenue Growth (5Y)

+102.92%

+227.63%

+294.75%

+317.42%

📊

Cost of Revenue Growth (10Y)

📊

Gross Profit

305

285

247

390

400

583

681

703

📊

Gross Profit Growth (1Y)

-6.53%

-13.27%

+57.61%

+2.57%

+45.73%

+16.81%

+3.30%

📊

Gross Profit Growth (5Y)

+31.06%

+104.34%

+175.20%

+184.28%

📊

Gross Profit Growth (10Y)

📊

Operating Expenses

249

211

192

321

336

412

462

450

📊

Operating Expenses Growth (1Y)

-15.24%

-9.08%

+67.22%

+4.82%

+22.56%

+12.19%

-2.66%

📊

Operating Expenses Growth (5Y)

+35.09%

+95.34%

+141.01%

+134.61%

📊

Operating Expenses Growth (10Y)

📊

Sell General Administrative

197

182

168

290

313

384

294

📊

Research and Development

📊

Other Income Expenses

462

137

📊

EBITDA

113

107

203

218

282

📊

EBITDA Growth (1Y)

-23.21%

-17.85%

+49.35%

-6.72%

+104.17%

+7.66%

+29.01%

📊

EBITDA Growth (5Y)

-12.12%

+133.68%

+206.21%

+295.04%

📊

EBITDA Growth (10Y)

📊

Depreciation and Amortization

📊

Operating Income

171

218

253

📊

Operating Income Growth (1Y)

+37.29%

-20.25%

+38.11%

-25.12%

+168.14%

+27.99%

+15.90%

📊

Operating Income Growth (5Y)

+13.22%

+121.14%

+254.91%

+311.34%

📊

Operating Income Growth (10Y)

📊

Interest Expense

📊

Pre Tax Income

103

173

235

270

📊

Tax Provision

📊

NET INCOME

113

188

183

📊

Net Income Growth (1Y)

-27.84%

-23.49%

+31.38%

+0.16%

+82.44%

+66.07%

-2.62%

📊

Net Income Growth (5Y)

-27.35%

+83.68%

+298.70%

+288.26%

📊

Net Income Growth (10Y)

📊

Basic EPS

2.22

1.6

1.23

1.61

2.94

3.63

4.35

📊

Diluted EPS

2.22

1.6

1.23

1.61

2.94

3.63

4.35

📊

Basic Average Shares

📊

Diluted Average Shares

📊

Ex-Dividend date
Payment date
Annual Dividend	2.61 (TWD)
Dividend Yield	5.16%
Shareholders Yield	4.97%
Next Earnings
Market cap	1.94B (TWD)
EPS (TTM)	4.35 (TWD)
P/E (TTM)	11.63 (TWD)
Last Close	50.60

Next Earnings
Market cap	1.94B (TWD)
EPS (TTM)	4.35 (TWD)
P/E (TTM)	11.63 (TWD)
Last Close	50.60 (TWD)

Ex-Dividend date
Payment date
Annual Dividend	2.61 (TWD)
Dividend Yield	5.16%
Shareholders Yield	4.97%
Next Earnings
Market cap	1.94B (TWD)
EPS (TTM)	4.35 (TWD)
P/E (TTM)	11.63 (TWD)
Last Close	50.60

Next Earnings
Market cap	1.94B (TWD)
EPS (TTM)	4.35 (TWD)
P/E (TTM)	11.63 (TWD)
Last Close	50.60 (TWD)